(Q35103342)

6 August 2017

1 reference

title

Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China (English)

1 reference

People's Republic of China

6 August 2017

0 references

author name string

Zhijian Xiao

1

1 reference

6 August 2017

Yushu Hao

2

1 reference

6 August 2017

Bingcheng Liu

3

1 reference

6 August 2017

Lingsheng Qian

4

1 reference

6 August 2017

1 September 2002

1 reference

6 August 2017

1 reference

6 August 2017

43

1 reference

6 August 2017

9

1 reference

6 August 2017

1763-1768

1 reference

Chronic myeloid leukemia: current treatment options

6 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006295

Crossref

reference URL

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006295

Crossref

reference URL

Meisoindigo for the treatment of chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006295

Crossref

reference URL

10.1080/1042819021000006295

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference